Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
Abstract
Article abstract The MIDAS Questionnaire was developed to assess headache-related disability with the aim of improving migraine care. Headache sufferers answer five questions, scoring the number of days, in the past 3 months, of activity limitations due to migraine. The internal consistency, test–retest reliability, and validity (accuracy) of the questionnaire were assessed in separate population-based studies of migraine sufferers. In addition, the face validity, ease of use, and clinical utility of the questionnaire were evaluated in a group of 49 physicians who independently rated disease severity and need for care in a diverse sample of migraine case histories. The test–retest Pearson correlation coefficient for the total MIDAS score was approximately 0.8. The MIDAS score was valid when compared with a reference diary-based measure of disability; the overall correlation between MIDAS and the diary-based measure was 0.63. The MIDAS score was also correlated with physicians’ assessments of need for medical care (r = 0.69). From studies completed to date, the MIDAS Questionnaire has been shown to be internally consistent, highly reliable, valid, and correlates with physicians’ clinical judgment. These features support its suitability for use in clinical practice. Use of the MIDAS Questionnaire may improve physician–patient communication about headache-related disability and may favorably influence health-care delivery for migraine patients.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Lipton RB, Amatniek JC, Ferrari MD, et al. Migraine: identifying and removing barriers to care. Neurology . 1994; 44 (suppl 4): 63–68.
2.
Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology . 1994; 44 (suppl 4): 24–39.
3.
Lipton RB, Goadsby PJ, Sawyer JPC, et al. Migraine: diagnosis and assessment of disability. Rev Contemp Pharmacother . 2000; 11: 63–73.
4.
Dahlöf C. Assessment of health-related quality of life in migraine. Cephalalgia . 1993; 13: 233–237.
5.
Jacobson GP, Ramadan NM, Aggarwal SK, et al. The Henry Ford Hospital Headache Disability Inventory. Neurology . 1994; 44: 837–842.
6.
Babiak LM, Miller DW, MacMillan JH, et al. Migraine-specific quality of life: a comparison of US and Canadian results. Qual Life Res . 1994; 3: 58.Abstract.
7.
Richard A, Henry P, Chezot G, et al. Quality of life and migraine, validation of the QVM questionnaire in hospital consultation and in general medicine [in French]. Therapie . 1993; 48: 89–96.
8.
Solomon GD, Skobieranda FG, Graff LA. Quality of life and well-being of headache patients: measurement by the Medical Outcomes Study Instrument. Headache . 1993; 33: 351–358.
9.
Osterhaus JT, Townsend RJ, Gandek B, et al. Measuring the functional status and well-being of patients with migraine headache. Headache . 1994; 34: 337–343.
10.
Wagner TH, Patrick DL, Galer BS, et al. A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache . 1996; 36: 484–492.
11.
National Academy of Sciences/Institute of Medicine (NAS/IOM). Disability in America: toward a national agenda for prevention. Washington, DC: NAS Press, 1991.
12.
Janca A, Prilipko, Costa E, Silva JA. The World Health Organization’s global initiative on neurology and public health. J Neurol Sci . 1997; 145: 1–2.
13.
Murray CJL, Lopez AD. The global burden of disease. Geneva: World Health Organization, 1996.
14.
Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet . 1997; 349: 1269–1276.
15.
Murray CJL, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet . 1997; 349: 1347–1352.
16.
Stewart WF, Lipton RB, Simon D, et al. Reliability of an illness severity measure for headache in a population sample of migraine sufferers. Cephalalgia . 1998; 18: 44–51.
17.
Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med . 1997; 39: 320–327.
18.
Von Korff MR, Stewart WF, Simon DJ, et al. Migraine and reduced work performance—a population-based diary study. Neurology . 1998; 50: 1741–1745.
19.
Rasmussen B, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health . 1992; 46: 443–446.
20.
de Lissovoy G, Lazarus SS. The economic cost of migraine. Present state of knowledge. Neurology . 1994; 44 (suppl 4): 56–62.
21.
Slater ND, Lipton RB, Stewart WF, et al. Doctor–patient communication about migraine disability. Neurology . 1999; 52 (suppl 2): A209.Abstract.
22.
Lipton RB, Stewart WF, MacGregor A, et al. Communication of migraine disability between physicians and patients. Cephalalgia . 1999; 19: 337.Abstract.
23.
Von Korff M, Ormel J, Keefe FJ, et al. Grading the severity of chronic pain. Pain . 1992; 50: 133–149.
24.
Stewart WF, Lipton RB, Simon D, et al. Validity of an illness severity measure for headache in a population sample of migraine sufferers. Pain . 1999; 79: 291–301.
25.
Stewart WF, Lipton RB, Kolodner K, et al. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia . 1999; 19: 107–114.
26.
Stewart WF, Lipton RB, Sawyer J. An international study to assess the reliability of the Migraine Disability Assessment (MIDAS) score. Neurology . 1999; 52: 988–994.
27.
Stewart WF, Lipton RB, Kolodner KB, et al. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain . 2000; 88: 41–52.
28.
Scher AI, Stewart WF, Lipton RB. Migraine and headache: a meta-analytic approach. In: Crombie IK, ed. Epidemiology of pain. Seattle: IASP Press, 1999: 159–170.
29.
Lipton RB, Stewart WF, Liberman J, et al. Validation of a computer assisted telephone interview for migraine (CATI-M): results of independent validation studies in the US and the UK. Headache . 2000; 40: 417.Abstract.
30.
Lipton RB, Stewart WF, Sawyer J, et al. Clinical utility of a new instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) Questionnaire. Headache. Submitted.
31.
Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol . 1991; 31: 295–299.
Information & Authors
Information
Published In
Copyright
© 2001.
Publication History
Published online: March 1, 2001
Published in print: March 1, 2001
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Comparative Effectiveness of Pharmacologic Treatments for the Prevention of Episodic Migraine Headache: A Systematic Review and Network Meta-analysis for the American College of Physicians, Annals of Internal Medicine, 178, 3, (369-380), (2025).https://doi.org/10.7326/ANNALS-24-00315
- A Study of Dizziness or Vertigo Cases Associated with Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis) in a Vertigo Outpatient Clinic, Journal of Clinical Medicine, 14, 2, (341), (2025).https://doi.org/10.3390/jcm14020341
- Prevalence of Patent Foramen Ovale in Patients with Non-Obstructive Coronary Artery Disease (PROVA) Study, Journal of Cardiovascular Development and Disease, 12, 4, (108), (2025).https://doi.org/10.3390/jcdd12040108
- Association between migraine severity and sleep quality: a nationwide cross-sectional study, Frontiers in Neurology, 16, (2025).https://doi.org/10.3389/fneur.2025.1529213
- Optimizing the management of patients with chronic migraine and neck pain: a prospective randomized trial with long-term follow-up, Russian neurological journal, 29, 6, (35-43), (2025).https://doi.org/10.30629/2658-7947-2024-29-6-35-43
- Engaging Patients with Headache in the Veterans Health Administration (VHA): ACTIvated Veterans Engagement Group (ACTIVE) to Improve Delivery of Patient-Centered Headache Services, Journal of Patient Experience, 12, (2025).https://doi.org/10.1177/23743735251314621
- Menstrual migraine prevalence and features in women with endometriosis: A common disabling comorbidity, Journal of Endometriosis and Pelvic Pain Disorders, 17, 1, (3-11), (2025).https://doi.org/10.1177/22840265241283520
- Gender-based discrimination and its influence on mental health symptoms among people living with and without migraine: A case-control study, Journal of Health Psychology, (2025).https://doi.org/10.1177/13591053251317069
- Setting higher standards for migraine prevention: A position statement of the International Headache Society, Cephalalgia, 45, 2, (2025).https://doi.org/10.1177/03331024251320608
- Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study , Headache: The Journal of Head and Face Pain, (2025).https://doi.org/10.1111/head.14925
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.